Insider Transactions Reported by 17 Insiders of Zenas BioPharma, Inc.

Symbol
ZBIO on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Zenas BioPharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
InnoCare Pharma Inc. 10%+ Owner $111,026,500 07 Oct 2025
Leon O. Moulder Jr. Chief Executive Officer, Director $68,316,615 +$3,432,669 +5.3% 02 Feb 2026
Enavate Sciences GP, LLC 10%+ Owner $63,943,103 16 Sep 2024
Fairmount Funds Management LLC Director $41,971,475 +$6,008,161 +17% 07 Oct 2025
SR ONE CAPITAL MANAGEMENT, LLC 10%+ Owner $36,440,005 +$2,399,985 +7.1% 09 Oct 2025
PATRICK G. ENRIGHT Director $35,070,702 +$2,250,027 +6.9% 09 Oct 2025
Jason Raleigh Nunn Director $22,294,505 +$1,200,002 +5.7% 09 Oct 2025
Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington 10%+ Owner $13,627,608 16 Sep 2024
Hongbo Lu Director $7,829,280 +$5,584,703 +249% 11 Feb 2026
Patricia L. Allen Director $523,509 +$499,746 +2103% 12 Feb 2026
Ting Xiao Director $77,600 07 Feb 2025
James P. Boylan Director 10 Jun 2025
Joseph L. Farmer President and Chief Operating Officer 10 Jun 2025
Jennifer A. Fox Chief Financial Officer and Chief Business Officer 10 Jun 2025
Lisa von Moltke Head of Research and Development and Chief Medical Officer 15 Apr 2025
Orlando Oliveira Chief Commercial Officer 10 Jun 2025
JOHN J. ORLOFF Director 10 Jun 2025

Recent Insider Transactions by Companies or Individuals for Zenas BioPharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.